LeMaitre Vascular Q2 2026: Sales Climb 10%, EPS Jumps 23%, Dividend Raised, Guidance Set
LMAT sits 16% above its 52-week low of $79.395.
Summary
LeMaitre Vascular reported Q2 2026 sales of $70.4 million (+10% YoY) and EPS of $0.74 (+23%), declared a $0.25 dividend, and provided Q3 and full-year guidance. The quarter was driven by a 34% surge in Artegraft sales and meaningful margin expansion.
Key Events · Earnings and Guidance · LMAT
-
Q2 2026 Results Beat on Profitability
Sales of $70.4M (+10% YoY) came in just shy of the $70.97M consensus, but EPS of $0.74 (+23%) topped expectations. Gross margin expanded 210 bps to 72.1%, and operating income rose 26% to $20.4M.
-
Artegraft Drives Growth
Artegraft sales surged 34% in Q2, now representing 21% of total sales. The product is approved in 56 countries, and the international launch is gaining speed.
-
Dividend Increased to $0.25/Share
The Board declared a quarterly dividend of $0.25 per share, payable September 3, 2026, to shareholders of record on August 20, 2026.
-
Q3 and Full-Year Guidance Issued
Q3 guidance: sales $66.3M-$68.3M (midpoint $67.3M, +10% YoY), EPS $0.66-$0.71. Full-year guidance: sales $274.3M-$278.3M (midpoint $276.3M, +11% YoY), EPS $2.84-$2.94.
Analysis · LMAT · Industrial Applications And Services
A strong second quarter for LeMaitre Vascular featured double-digit sales and earnings growth, fueled by the international rollout of Artegraft and disciplined operating leverage. Gross margin widened 210 basis points to 72.1%, while operating income advanced 26% on a flat headcount. The board declared a $0.25 quarterly dividend and issued Q3 and full-year guidance that signals sustained momentum. With $376 million in cash, the company retains ample strategic flexibility. Although the top line slightly missed the consensus estimate of $70.97 million, profitability exceeded expectations, and the Q3 sales guidance midpoint sits below the current quarter's run rate, which may moderate investor enthusiasm.
At the time of this filing, LMAT was trading at $92.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $79.40 to $118.01. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.